Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study

2020 ◽  
Vol 67 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Ilenia Pirola ◽  
Mario Rotondi ◽  
Alessandra Cristiano ◽  
Filippo Maffezzoni ◽  
Daniela Pasquali ◽  
...  
2020 ◽  
Vol 67 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Ilenia Pirola ◽  
Mario Rotondi ◽  
Alessandra Cristiano ◽  
Filippo Maffezzoni ◽  
Daniela Pasquali ◽  
...  

2021 ◽  
pp. 1-5
Author(s):  
Manal Mustafa Khadora ◽  
Maysa Saleh ◽  
Rawah Idres ◽  
Sura Ahmed Al-Doory ◽  
Mahmoud Ahmed Radaideh

Autoimmune thyroiditis is very rare etiology of primary hypothyroidism in infancy. Hypothyroidism has a wide range of clinical presentation, from subclinical hypothyroidism to overt type. It is unclear what pathological mechanisms connect thyroid function and erythropoiesis or how thyroid disease can contribute to anemia. We report a 12-month-old infant who presented with anemia associated with early onset of overt autoimmune thyroiditis. The peculiarity of our case enables us to draw attention of physician to consider acquired hypothyroidism in the differential diagnosis of unexplained anemia even if the neonatal screening is normal and congenital hypothyroidism is a remote possibility.


2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Mara Ventura ◽  
Miguel Melo ◽  
Francisco Carrilho

Introduction.Selenium is a micronutrient embedded in several proteins. In adults, the thyroid is the organ with the highest amount of selenium per gram of tissue. Selenium levels in the body depend on the characteristics of the population and its diet, geographic area, and soil composition. In the thyroid, selenium is required for the antioxidant function and for the metabolism of thyroid hormones.Methods.We performed a review of the literature on selenium’s role in thyroid function using PubMed/MEDLINE.Results.Regarding thyroid pathology, selenium intake has been particularly associated with autoimmune disorders. The literature suggests that selenium supplementation of patients with autoimmune thyroiditis is associated with a reduction in antithyroperoxidase antibody levels, improved thyroid ultrasound features, and improved quality of life. Selenium supplementation in Graves’ orbitopathy is associated with an improvement of quality of life and eye involvement, as well as delayed progression of ocular disorders. The organic form of selenium seems to be the preferable formulation for supplementation or treatment.Conclusion.Maintaining a physiological concentration of selenium is a prerequisite to prevent thyroid disease and preserve overall health. Supplementation with the organic form is more effective, and patients with autoimmune thyroiditis seem to have benefits in immunological mechanisms. Selenium supplementation proved to be clinically beneficial in patients with mild to moderate Graves’ orbitopathy.


1994 ◽  
Vol 17 (8) ◽  
pp. 641-646 ◽  
Author(s):  
Nicola Custro ◽  
V. Scafidi ◽  
R. Lo Baido ◽  
L. Nastri ◽  
G. Abbate ◽  
...  

Author(s):  
Davide Nacamulli ◽  
Caterina Mian ◽  
Daniela Petricca ◽  
Francesca Lazzarotto ◽  
Susi Barollo ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Yaofu Fan ◽  
Shuhang Xu ◽  
Huifeng Zhang ◽  
Wen Cao ◽  
Kun Wang ◽  
...  

Many studies have reported that selenium (Se) has a close relationship with autoimmune thyroiditis (AIT). The therapeutic effect of Se supplementation in AIT treatment remains unclear. The objective of the present study was to determine the efficacy of Se supplementation for the treatment of AIT. A structured literature search was undertaken to identify all randomized controlled trials conducted in patients with AIT receiving Se supplementation or placebo. Nine studies enrolling a total of 787 patients were included. The results showed that Se supplementation with duration 6 months significantly dropped the TPOAb titers but did not decrease the TgAb titers. Patients assigned to Se supplementation for 12-month duration showed significantly lower TPOAb titers and TgAb titers. Patients after Se supplementation had a higher chance to improve the mood or well-being compared with controls. Se supplementation is associated with a significant decrease in TPOAb titers at 6 and 12 months; meanwhile, the TgAb titers can be dropped at 12 months. After Se supplementation treatment, patients had a higher chance to improve the mood without significant adverse events.


Sign in / Sign up

Export Citation Format

Share Document